Related Experiment Videos
Dextran augments delayed-type hypersensitivity by interrupting one limb of the suppressor cascade
Journal of Immunology (Baltimore, Md. : 1950)
|April 1, 1985
Summary
Dextran enhances delayed-type hypersensitivity (DTH) responses in mice by partially blocking a suppressor pathway involving macrophages. This immunomodulatory effect accelerates DTH development and requires fewer cells for adoptive transfer, indicating enhanced immune function.
Area of Science:
- Immunology
- Immunomodulation
- Contact Hypersensitivity
Background:
- Delayed-type hypersensitivity (DTH) is a critical immune response.
- Suppressor T cells (Ts1, Ts3) and macrophages regulate DTH.
- Understanding immunomodulatory agents like dextran is key to immune response manipulation.
Purpose of the Study:
- To investigate the immunomodulatory effect of dextran on DTH development.
- To elucidate the mechanisms by which dextran enhances DTH.
- To determine dextran's impact on specific suppressor cell pathways.
Main Methods:
- Induction of hapten-specific DTH in mice.
- Administration of dextran prior to antigen challenge.
- Kinetic analysis of DTH development.
- Adoptive transfer of splenic cells.
- Assessment of suppressor T cell (Ts1, Ts3) and macrophage function.
Main Results:
- Dextran administration significantly enhanced DTH response levels and accelerated its development.
- Adoptive transfer studies showed reduced cell numbers were needed from dextran-treated mice.
- Dextran partially blocked the Ts1-macrophage suppressor pathway by interfering with macrophage suppressor factor production.
- The Ts1-Ts3 suppressor pathway remained unaffected by dextran.
Conclusions:
- Dextran acts as an immunomodulator, enhancing DTH responses in mice.
- The enhancement is mediated by the blockade of a specific macrophage-dependent suppressor pathway.
- Dextran's targeted interference with immune suppression offers potential for therapeutic applications.